Collectively, our findings reveal that SM may decrease the expression levels of Nrf2 and β-catenin, inhibiting the relevant signaling pathways, activating ferroptosis, and diminishing CSCs, ultimately leading to therapeutic effects against CRC. This evidence concerns the gene NFE2L2 and colorectal carcinoma.